Phillip P. Chan
2022
In 2022, Phillip P. Chan earned a total compensation of $1.1M as Chief Executive Officer at Cytosorbents, a 38% decrease compared to previous year.
Compensation breakdown
| Bonus | $47,078 |
|---|---|
| Option Awards | $410,633 |
| Salary | $482,851 |
| Stock Awards | $154,050 |
| Other | $12,000 |
| Total | $1,106,612 |
Chan received $482.9K in salary, accounting for 44% of the total pay in 2022.
Chan also received $47.1K in bonus, $410.6K in option awards, $154.1K in stock awards and $12K in other compensation.
Rankings
In 2022, Phillip P. Chan's compensation ranked 2,834th out of 5,760 executives tracked by ExecPay. In other words, Chan earned more than 50.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,834 out of 5,760 | 51st |
Division Manufacturing | 1,580 out of 3,136 | 50th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 190 out of 485 | 61st |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 127 out of 347 | 63rd |
Industry Surgical and Medical Instruments and Apparatus | 105 out of 253 | 59th |
Source: SEC filing on April 21, 2023.
Chan's colleagues
We found three more compensation records of executives who worked with Phillip P. Chan at Cytosorbents in 2022.